Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas

Abstract

Amplification of genes in the 12q13-15 region occurs frequently in several malignancies including osteosarcoma. The products of these amplified genes are thought to provide cancer cells with a selective growth advantage; however, the specific gene(s) driving this amplicon is unknown. We have previously shown that the SAS gene is amplified in most parosteal osteosarcomas. In this study we analysed additional putative growth regulatory genes in this chromosomal region in 24 primary osteosarcoma specimens. CDK4 and SAS were co-amplified in 6/6 parosteal tumors, and MDM2 was also amplified in 4/5 parosteal cases. In comparison, amplification occurred in only 2/16 classical intramedullary osteosarcomas and involved the SAS gene. Each amplified gene had a correspondingly elevated mRNA level. Four high grade intramedullary tumors had elevated mRNA expression of SAS, but did not exhibit gene amplification. Gene amplification/overexpression was not associated with metastatic disease and did not change markedly with tumor progression, as evidenced by analysis of sequential tumor specimens from eight patients. Three other genes in the 12q13-15 region (CDK2, WNT1 and WNT10b) were not amplified in any of the tumors. The different patterns of gene amplification and overexpression of CDK4, SAS and MDM2 in parosteal and intramedullary osteosarcomas may help explain the disparity in the biological behaviour of these two types of osteosarcoma.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M and Miyake M. . 1996 Cancer Res. 56: 1751–1755.

  • Akiyama T, Ohuchi T, Sumida S, Matsumoto K and Toyoshima K. . 1992 Proc. Natl. Acad. Sci. USA 89: 7900–7904.

  • Arheden K, Mandahl N, Strombeck B, Isaksson M and Mitelman, F. . 1988 Cytogenet. Cell. Genet. 47: 86–87.

  • Barak Y, Juven T, Haffner R and Oren M. . 1993 EMBO J. 12: 461–468.

  • Berner J, Forus A, Elkahloun A, Meltzer PS, Fodstad O and Myklebost O. . 1996 Genes Chromo. Cancer 17: 254–259.

  • Bui TD, Rankin J, Smith K, Huguet EL, Ruben S, Strachan T, Harris AL and Lindsay S. . 1997 Oncogene 14: 1249–1253.

  • Chen J, Marechal V and Levine AJ. . 1993 Mol. Cell. Biol. 13: 4107–4114.

  • Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ. . 1994 Cancer Res. 54: 794–799.

  • Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W and Van Den Berghe H. . 1993 Cancer Genet. Cytogenet. 68: 85–90.

  • Demetrick DJ, Zhang H and Beach DH. . 1994 Cytogenet. Cell Genet. 66: 72–74.

  • Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC. . 1995 Science 268: 884–886.

  • Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC and Isaacs JT. . 1996 Cancer Res. 56: 4387–4390.

  • Dubs-Poterszman MC, Tocque B and Wasylyk B. . 1995 Oncogene 11: 2445–2449.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Elkahloun AG, Bittner M, Hoskins K, Gemmill R and Meltzer PS. . 1996 Genes Chromosom. Cancer 17: 205–214.

  • Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM. . 1993a Cell 73: 487–497.

  • Ewen ME, Sluss HK, Whitehouse LL and Livingston DM. . 1993b Cell 74: 1009–1020.

  • Fakharzadeh SS, Trusko SP and George DL. . 1991 EMBO J. 10: 1565–1569.

  • Fischer U, Meltzer P and Meese E. . 1996 Hum. Genet. 98: 625–628.

  • Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O and Myklebost O. . 1993 Cell Growth Differ. 4: 1065–1070.

  • Forus A, Olde Weghuis D, Smeets D, Fodstad O, Myklebost O and Geurts van Kessel A. . 1995 Genes Chromosom. Cancer 14: 8–14.

  • Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M and Buchler MW. . 1996 Cancer Res. 56: 4876–4880.

  • Jankowski SA, Mitchell DS, Smith SH, Trent JM and Meltzer PM. . 1994 Oncogene 9: 1205–1211.

  • Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ. . 1993 Genes Dev. 7: 331–342.

  • Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look AT. . 1993 Cancer Res. 53: 5535–5541.

  • Ladanyi M, Cha C, Lewis R, Jhanwar SC, Huvos AG and Healey JH. . 1993 Cancer Res. 53: 16–18.

  • Latham KM, Eastman SW, Wong A and Hinds PW. . 1996 Mol. Cell. Biol. 16: 4445–4455.

  • Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW and Vogelstein B. . 1993 Cancer Res. 53: 2231–2234.

  • Lee PD, Noble-Topham SE, Bell RS and Andrulis IL. . 1996 Br. J. Cancer 74: 1046–1050.

  • Li Y, Jenkins CW, Nichols MA and Xiong Y. . 1994 Oncogene 9: 2261–2268.

  • Lonardo F, Ueda T, Huvos AG, Healey J and Ladanyi M. . 1997 Cancer 79: 1541–1547.

  • Lundgren K, Montes de Ocal Luna R, McNeil YB and Emerick EP, et al. 1997 Genes Dev. 11: 714–725.

  • Maelandsmo GM, Berner J, Florenes VA, Forus A, Hovig E, Fodstad O and Myklebost O. . 1995 Br. J. Cancer 72: 393–398.

  • Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato J. . 1994 Mol. Cell. Biol. 14: 2066–2076.

  • Meltzer PS, Jankowski SA, Dal Cin P, Sandberg AA, Paz IB and Coccia MA. . 1991 Cell Growth Differ. 2: 495–501.

  • Miller CW, Aslo A, Won A, Tan M, Lampkin B and Koeffler HP. . 1996 J. Cancer Res. Clin. Oncol. 122: 559–565.

  • Momand J, Zambetti GP, Olson DC, George D and Levine AJ. . 1992 Cell 69: 1237–1245.

  • Mousses S, McAuley L, Bell RS, Kandel R and Andrulis IL. . 1996 Mod. Pathol. 9: 1–6.

  • Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y and Sasaki MS. . 1995 Int. J. Cancer 64: 342–346.

  • Nilbert M, Rydholm A, Mitelman F, Meltzer PS and Mandahl N. . 1995 Cancer Genet. Cytogenet. 83: 32–36.

  • Noble-Topham SE, Burrow SR, Eppert K, Kandel RA, Meltzer PS, Bell RS and Andrulis IL. . 1996 J. Orthop. Res. 14: 700–705.

  • Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B and Von Hoff DD, et al. 1990 Proc. Natl. Acad. Sci. USA 87: 7160–7164.

  • Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B. . 1992 Nature 358: 80–83.

  • Orndal C, Mandahl N, Rydholm A, Willen H, Brosjo O, Heim S and Mitelman F. . 1992 Cancer Genet. Cytogenet. 60: 170–175.

  • Raymond AK. . 1991 Clin. Orthop. 270: 140–148.

  • Reifenberger G, Liu L, Ichimura K, Schmidt EE and Collins VP. . 1993 Cancer Res. 53: 2736–2739.

  • Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS and Collins VP. . 1994 Cancer Res. 54: 4299–4303.

  • Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS and Collins VP. . 1996 Cancer Res. 56: 5141–5145.

  • Sambrook J, Fritsch EF and Maniatis T. . 1989 Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press: New York.

    Google Scholar 

  • Seeger RC, Brodeur GM, Sather H, Dalton A, Seigel SE, Wong KY and Hammond D. . 1985 N. Eng. J. Med. 313: 1111–1116.

  • Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I and Gottesman MM. . 1986 Science 232: 643–645.

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. . 1987 Science 235: 177–182.

  • Smith SH, Weiss SW, Jankowski SA, Coccia MA and Meltzer PS. . 1992 Cancer Res. 52: 3746–3749.

  • Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell VH, Wierzbicki R, Malcolm AJ, Kirkpatrick A, Uscinska BM, Van Glabbeke M and Machin D. . 1997 Lancet 350: 911–917.

  • Su YA, Trent JM, Guan XY and Meltzer PS. . 1994 Proc. Natl. Acad. Sci. USA 91: 9121–9125.

  • Suijkerbuijk RF, Olde Weghuis DEM, Van Den Berg M, Pedeutour F, Forus A, Myklebost O, Glier C, Turc-Carel C and Geurts van Kessel A. . 1994 Genes Chromosom. Cancer 9: 292–295.

  • Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E and Knuutila S. . 1996a Genes Chromosom. Cancer 16: 31–34.

  • Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I and Knuutila S. . 1996b Genes Chromosom. Cancer 15: 89–94.

  • Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Bohling T, Karaharju E, Hyytinen E, Knuutila S and Kallioniemi O. . 1995 Cancer Res. 55: 1334–1338.

  • Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS and Little JB, et al.. 1992 Cancer Res. 52: 6194–6199.

  • Tsai LH, Lees E, Faha B, Harlow E and Riabowol K. . 1993 Oncogene 8: 1593–1602.

  • Unni KK, Dahlin DC, Beabout JW and Ivins JC. . 1976 Cancer 37: 2466–2475.

  • van't Veer LJ, Geurts van Kessel AHM, van Heerikhuizen H, van Ooyen A and Nusse R. . 1984 Mol. Cell. Biol. 4: 2532–2534.

  • Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner J, Myklebost O and Knuutila S. . 1997 Genes Chromosom. Cancer 18: 66–70.

  • Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB and Vogelstein B. . 1986 Science 233: 461–464.

Download references

Acknowledgements

We acknowledge the excellent technical assistance of Sandra Noble-Topham and Laura McAuley. We thank the Department of Pathobiology and Laboratory Medicine, Mount Sinai Hospital and orthopaedic surgeons M Rock, R Grimer, J Healey, C Conrad III and C Beauchamp for osteosarcoma specimens. This work was supported by grants from the National Cancer Institute of Canada (ILA and RSB).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wunder, J., Eppert, K., Burrow, S. et al. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Oncogene 18, 783–788 (1999). https://doi.org/10.1038/sj.onc.1202346

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202346

Keywords

This article is cited by

Search

Quick links